Abstract
Approximately 50% of all cutaneous melanomas harbor activating BRAF V600 mutations; among, these 10-30% carry the V600K mutation. Clinically, patients......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
